BioCentury
ARTICLE | Targets & Mechanisms

Moving beyond the active site: why allostery is newly in fashion

How a new class of biotechs is turning allostery from serendipitous to systematic

June 20, 2019 10:41 PM UTC
Updated on Oct 7, 2019 at 2:36 AM UTC

A new crop of companies is creating tools to systematize development of allosteric protein inhibitors, finally moving industry beyond the one-off compounds that have been found by accident.

Allosteric pockets on proteins have long been viewed as promising alternatives to active sites for controlling protein function. The problem has been finding them. ...